171 related articles for article (PubMed ID: 10536724)
1. Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment.
Sandmair AM; Loimas S; Poptani H; Vainio P; Vanninen R; Turunen M; Tyynelä K; Vapalahti M; Ylä-Herttuala S
Acta Neurochir (Wien); 1999; 141(8):867-72; discussion 872-3. PubMed ID: 10536724
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
4. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
[TBL] [Abstract][Full Text] [Related]
6. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.
Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2010 Feb; 17(2):86-96. PubMed ID: 19763147
[TBL] [Abstract][Full Text] [Related]
7. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.
Hlavatý J; Hlubinová K; Altanerová V; Líska J; Altaner C
Neoplasma; 1997; 44(6):342-7. PubMed ID: 9605005
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
11. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
[TBL] [Abstract][Full Text] [Related]
12. In vivo 31P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene.
Stegman LD; Ben-Yoseph O; Freyer JP; Ross BD
NMR Biomed; 1996 Dec; 9(8):364-8. PubMed ID: 9176891
[TBL] [Abstract][Full Text] [Related]
13. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
15. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.
Martinet O; Schreyer N; Reis ED; Joseph JM
Eur J Surg Oncol; 2003 May; 29(4):351-7. PubMed ID: 12711288
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model.
Nafe C; Cao YJ; Quinones A; Dobberstein KU; Kramm CM; Rainov NG
Life Sci; 2003 Aug; 73(14):1847-60. PubMed ID: 12888123
[TBL] [Abstract][Full Text] [Related]
19. Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide.
Stedt H; Samaranayake H; Pikkarainen J; Määttä AM; Alasaarela L; Airenne K; Ylä-Herttuala S
Gene Ther; 2013 Dec; 20(12):1165-71. PubMed ID: 24067866
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
